98 related articles for article (PubMed ID: 7814065)
21. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
23. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Hefler L; Tempfer C; Heinze G; Mayerhofer K; Breitenecker G; Leodolter S; Reinthaller A; Kainz C
Br J Cancer; 1999 Nov; 81(5):855-9. PubMed ID: 10555758
[TBL] [Abstract][Full Text] [Related]
24. [Immunologic disturbances in patients with idiopathic posterior uveitis].
Kubicka-Trzaska A
Klin Oczna; 2000; 102(4):253-8. PubMed ID: 11291295
[TBL] [Abstract][Full Text] [Related]
25. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
26. Serum immunoglobulin levels in neoplastic disorder of breast.
Ahmad S; Faruqi NA; Arif SH; Akhtar S
J Indian Med Assoc; 2002 Aug; 100(8):495-6. PubMed ID: 12675180
[TBL] [Abstract][Full Text] [Related]
27. Immunodiagnosis in bone and joint tuberculosis.
Singh SB; Goel SC
J Indian Med Assoc; 2000 Mar; 98(3):97-9. PubMed ID: 11016160
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Ig/Ig two-component-determined circulating immune complexes (TCIC) provide new insights into host immunity.
Wang S; Yang T; Zhang J; Xiao S; Peng X
Int Immunopharmacol; 2003 Oct; 3(10-11):1549-55. PubMed ID: 12946452
[TBL] [Abstract][Full Text] [Related]
29. Considerations on the changes of certain immunologic parameters in occupational allergic bronchial asthma due to textile fibers.
Mitrea CM; Cojocaru M
Rom J Intern Med; 1998; 36(1-2):77-83. PubMed ID: 10660972
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber.
Biocina-Lukenda D; Cekić-Arambasin A; Markeljević J; Buković D
Coll Antropol; 2008 Mar; 32(1):161-3. PubMed ID: 18496909
[TBL] [Abstract][Full Text] [Related]
32. Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.
Gerçel-Taylor C; Bazzett LB; Taylor DD
Gynecol Oncol; 2001 Apr; 81(1):71-6. PubMed ID: 11277653
[TBL] [Abstract][Full Text] [Related]
33. [Interdependency between titers of aniretinal antibodies and selected immune system parameters in serum of patients with endogenous posterior uveitis].
Kubicka-Trzaska A
Klin Oczna; 2000; 102(4):259-62. PubMed ID: 11291296
[TBL] [Abstract][Full Text] [Related]
34. [Free amino acids in normal and carcinomatous ovarian tissue in correlation with serum level--tumor diagnostic possibilities].
Elling D; Bader K
Zentralbl Gynakol; 1987; 109(16):1013-22. PubMed ID: 3673322
[TBL] [Abstract][Full Text] [Related]
35. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
[TBL] [Abstract][Full Text] [Related]
36. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
Wang J; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
[TBL] [Abstract][Full Text] [Related]
37. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
[TBL] [Abstract][Full Text] [Related]
38. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.
Sier CF; Stephens R; Bizik J; Mariani A; Bassan M; Pedersen N; Frigerio L; Ferrari A; Danø K; Brünner N; Blasi F
Cancer Res; 1998 May; 58(9):1843-9. PubMed ID: 9581823
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
40. [The immune changes at the beginning of pregnancy].
Milchev N; Pekhlivanov B; Krŭsteva M; Chalŭkova Zh; Stankova G
Akush Ginekol (Sofiia); 1990; 29(1):13-6. PubMed ID: 2372091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
